|
USP32 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.958000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.388400E-01 |
| Normal-vs-Stage2 |
2.244600E-01 |
| Normal-vs-Stage3 |
7.481700E-02 |
| Normal-vs-Stage4 |
2.464600E-01 |
| Stage1-vs-Stage2 |
3.080600E-01 |
| Stage1-vs-Stage3 |
1.080350E-01 |
| Stage1-vs-Stage4 |
1.300400E-01 |
| Stage2-vs-Stage3 |
7.447600E-01 |
| Stage2-vs-Stage4 |
5.472400E-01 |
| Stage3-vs-Stage4 |
6.817600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.059410E-01 |
| Normal-vs-AfricanAmerican |
8.243400E-01 |
| Normal-vs-Asian |
4.049200E-01 |
| Caucasian-vs-AfricanAmerican |
3.097800E-01 |
| Caucasian-vs-Asian |
4.451800E-01 |
| AfricanAmerican-vs-Asian |
2.139600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.528400E-01 |
| Normal-vs-Female |
2.797800E-04 |
| Male-vs-Female |
1.785070E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.629000E-01 |
| Normal-vs-Extreme_Weight |
7.224600E-01 |
| Normal-vs-Obese |
1.543630E-01 |
| Normal-vs-Extreme_Obese |
5.233000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.349200E-01 |
| Normal_Weight-vs-Obese |
9.226200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.786800E-01 |
| Extreme_Weight-vs-Obese |
1.055820E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.333400E-01 |
| Obese-vs-Extreme_Obese |
9.729200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.394480E-02 |
| Normal-vs-Age(41-60Yrs) |
1.118020E-02 |
| Normal-vs-Age(61-80Yrs) |
8.284800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.230000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.059800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.175780E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.397300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.162400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.562200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.906000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.185800E-01 |
| Normal-VS-Type2 PRCC |
6.836300E-02 |
| Normal-VS-KIRP CIMP |
2.928100E-02 |
| Normal-VS-Unclassified PRCC |
6.440000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.005000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.121900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.026100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.717700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.580200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.207220E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.196000E-01 |
| Normal-vs-N1 |
1.726430E-02 |
| Normal-vs-N2 |
2.491000E-01 |
| N0-vs-N1 |
3.290100E-02 |
| N0-vs-N2 |
1.095000E-01 |
| N1-vs-N2 |
6.730200E-01 |
|
|
